NCT05083455View on ClinicalTrials.gov

Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

89,215

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

July 22, 2021

Conditions
Deep Vein Thrombosis, Pulmonary Embolus
Interventions
DRUG

Rivaroxaban

Any rivaroxaban dispensing claim is used as the exposure group

DRUG

Enoxaparin

Any enoxaparin dispensing claim is used as the reference group

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT05083455 - Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter